1 Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines[J]. Hepatology,2000,31(4):1005-1013. 2 Kaplan MM,Gershwin ME. Primary biliary cirrhosis[J]. N Engl J Med,2005,353(12):1261-1273. 3 Moteki S,Leung PS,Coppel RL,et al. Use ofa designer triple expression hybrid clone for three different lipoyl domain for thedetection of antimitochondrial autoantibodies[J]. Hepatology,1996,24(1):97-103. 4 Courvalin JC,Lassoued K,Bartnik E,et al. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies inprimary biliary cirrhosis is the major glycoprotein of the nuclear pore[J]. J ClinInvest,1990,86(1):279-85. 5 Szostecki C,Guldner HH,Netter HJ,et al. Isolation and characterization ofcDNA encoding a human nuclear antigen predominantly recognized byautoantibodies from patients with primary biliary cirrhosis[J]. J Immunol,1990,145(12):4338-4347. 6 Miyakawa H,Tanaka A,Kikuchi K,et al. Detection 7 of antimiochondrial autoantibodies in immunofluoresc-ent AMA-negative patients with primary biliary cirrhosis using recombinant autoantibodies autoantigens[J]. Hepatology,2001,34(2):243-248. 8 金燕,郭婧婧.自身抗体在原发性胆汁性肝硬化中的应用分析[J]. 中国现代医学杂志,2005,15(1):76-80. 9 张福奎,贾继东,钱林学,等. 抗线粒体抗体阴性原发性胆汁性肝硬化的临床特征[J]. 肝脏,2002,7(3):150-152. 10 M arvin J,Fritzler,M ichael P,et al. Anti-mitochond rial autoantibod ies [J]. C lin App lied Imm unol Rev,2002,3(3):87-113. 11 姚定康,谢渭芬,陈伟忠,等.抗线粒体抗体及其分型对原发性胆汁性肝硬化的诊断价值[J].中华肝脏病杂志,2005,13(1):9-11. 12 Lindor KD,Gershwin ME,Poupon R,et al. American Association for Study of Liver Diseases [J].Primary biliary cirrhosis[J]. Hepatology,2009,50(1):291-308. 13 Weijia D,Xiao Juan O,Qian Yi W. Diagnostic relevance andclinical significance of MIT3,anti-gp210 and anti-sp100 in Chinesepatients with PBC[J]. APASL 2013. 14 李卓敏,赵丹彤.原发性胆汁性肝硬化所致肝癌患者自身抗体特征分析[J].中国实验诊断学,2014,18(1):59-61. 15 肖琼怡,郭致平.原发性胆汁性肝硬化临床特点分析[J].中国实用医药,2014,2(2):83-84. 16 Haiying L,Gary LM. PBC Screen:an IgG/IgA dual isotypeELISA detecting multiple mitochondrial and nuclear autoantibodiesspecific for primary biliary cirrhosis[J]. Journal of Autoimmunity,2010,35(4):436-442. 17 Nishio A,Van de Water J,Leung PS,et al.Comparative studies of antimitochondrial autoantibodies in sera and bile inprimary biliary cirrhosis[J]. Hepatology,1997,25(5):1085-1089 18 Malmborg AC,Shultz DB,Luton F,et al.Penetration and co-localization in MDCK cell mitochondria of IgA derivedfrom patients with primary biliary cirrhosis[J]. J Autoimmun 1998,11(5):573-580. 19 Gabeta S,Norman GL,Liaskos C,et al.Diagnostic relevance and clinical significance of the new enhanced performanceM2(MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies inprimary biliary cirrhosis[J]. J Clin Immunol,2007,27(4):378-387. 20 Nakajima M,Shimizu H,Miyazaki A,et al. Detectionof IgA,IgM,and IgG subclasses of anti-M2 antibody by immunoblotting inautoimmune cholangitis:is autoimmune cholangitis an early stage of primarybiliary cirrhosis?[J]. J Gastroenterol,1999,34(5):607-612. |